Biochemistry 40:1413442, PMID: 11714266 Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C, Heintz NH, Heim J, Ho YS, Matthews DE, Wouters EF, JanssenHeininger YM (2006) Dynamic redox control of NF-kappaB through glutaredoxin-regulated S -glutathionylation of inhibitory kappaB kinase beta
The peptide has also been successfully tested for vascular injury and blood flow disturbances in rats, particularly in cases of lab-induced vessel occlusion of the mesenteric vein and pancreaticoduodenal vein
I remember thinking, Interesting
[7] References [edit] Pharmacology
Because of its short and variable half-life and its context-dependent activity profile, many published protocols time the dose close to the desired observation window, often in the evening